梅斯作为媒体参加第二届雪乡(血管 内分泌)医学论坛暨中国微循环周围血管疾病专委会糖尿病足学组年会通知

2017-01-23 MedSci MedSci原创

梅斯作为媒体参加第二届雪乡(血管 内分泌)医学论坛暨中国微循环周围血管疾病专委会糖尿病足学组年会通知







版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1682285, encodeId=7f6f168228582, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Fri Jun 16 10:20:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=173040, encodeId=b0051e304025, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Jan 28 15:30:58 CST 2017, time=2017-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718647, encodeId=47a01e18647b4, content=<a href='/topic/show?id=58ee50609ee' target=_blank style='color:#2F92EE;'>#微循环#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50609, encryptionId=58ee50609ee, topicName=微循环)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b0832589054, createdName=smlt2019, createdTime=Wed Mar 22 07:20:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276958, encodeId=618e12e69583e, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jan 25 00:20:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498110, encodeId=519c1498110db, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Jan 25 00:20:00 CST 2017, time=2017-01-25, status=1, ipAttribution=)]
    2017-06-16 gwc392
  2. [GetPortalCommentsPageByObjectIdResponse(id=1682285, encodeId=7f6f168228582, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Fri Jun 16 10:20:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=173040, encodeId=b0051e304025, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Jan 28 15:30:58 CST 2017, time=2017-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718647, encodeId=47a01e18647b4, content=<a href='/topic/show?id=58ee50609ee' target=_blank style='color:#2F92EE;'>#微循环#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50609, encryptionId=58ee50609ee, topicName=微循环)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b0832589054, createdName=smlt2019, createdTime=Wed Mar 22 07:20:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276958, encodeId=618e12e69583e, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jan 25 00:20:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498110, encodeId=519c1498110db, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Jan 25 00:20:00 CST 2017, time=2017-01-25, status=1, ipAttribution=)]
    2017-01-28 doctorJiangchao

    继续学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1682285, encodeId=7f6f168228582, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Fri Jun 16 10:20:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=173040, encodeId=b0051e304025, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Jan 28 15:30:58 CST 2017, time=2017-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718647, encodeId=47a01e18647b4, content=<a href='/topic/show?id=58ee50609ee' target=_blank style='color:#2F92EE;'>#微循环#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50609, encryptionId=58ee50609ee, topicName=微循环)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b0832589054, createdName=smlt2019, createdTime=Wed Mar 22 07:20:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276958, encodeId=618e12e69583e, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jan 25 00:20:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498110, encodeId=519c1498110db, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Jan 25 00:20:00 CST 2017, time=2017-01-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1682285, encodeId=7f6f168228582, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Fri Jun 16 10:20:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=173040, encodeId=b0051e304025, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Jan 28 15:30:58 CST 2017, time=2017-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718647, encodeId=47a01e18647b4, content=<a href='/topic/show?id=58ee50609ee' target=_blank style='color:#2F92EE;'>#微循环#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50609, encryptionId=58ee50609ee, topicName=微循环)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b0832589054, createdName=smlt2019, createdTime=Wed Mar 22 07:20:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276958, encodeId=618e12e69583e, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jan 25 00:20:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498110, encodeId=519c1498110db, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Jan 25 00:20:00 CST 2017, time=2017-01-25, status=1, ipAttribution=)]
    2017-01-25 一闲
  5. [GetPortalCommentsPageByObjectIdResponse(id=1682285, encodeId=7f6f168228582, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Fri Jun 16 10:20:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=173040, encodeId=b0051e304025, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Jan 28 15:30:58 CST 2017, time=2017-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718647, encodeId=47a01e18647b4, content=<a href='/topic/show?id=58ee50609ee' target=_blank style='color:#2F92EE;'>#微循环#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50609, encryptionId=58ee50609ee, topicName=微循环)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b0832589054, createdName=smlt2019, createdTime=Wed Mar 22 07:20:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276958, encodeId=618e12e69583e, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jan 25 00:20:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498110, encodeId=519c1498110db, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Jan 25 00:20:00 CST 2017, time=2017-01-25, status=1, ipAttribution=)]

相关资讯

Hypertens Pregnancy:妊高症的毛细血管改变

妊娠期高血压疾病是产科常见疾患,占全部妊娠的5%~10%,所造成的孕产妇死亡约占妊娠相关的死亡总数的10%~16%,是孕产妇死亡的第二大原因。其主要症状有高血压、蛋白尿、水肿等。因其病因及发病机制不清,由该病引起的高孕产妇及围生儿的死亡率和并发症一直威胁着人类健康并困扰着临床医生。近期Rusavy Z进行了一项研究,探究妊娠期高血压疾病孕妇体内毛细血管直径、功能等变化情况,进一步推测该疾病影响下体

J Clin Periodonto:牙周炎和视网膜微循环在动脉粥样硬化中的风险

J Clin Periodonto:牙周炎和视网膜微循环在动脉粥样硬化中的风险关键词:牙周炎 视网膜 微循环在发达国家,牙周疾病(PDs)几乎影响了50%的30岁以上人群。PDs是细菌引起的炎症性疾病,累及支持牙齿的软硬组织。牙根表面的菌斑生物膜是始动因子,破坏牙周结缔组织和牙槽骨。如果不治疗PDs,病情继续发展,最终结果是牙齿脱落。慢性牙周炎是PDs最常见的一种类型,与许多全身状况有关,包括血

2016中国微循环学会周围血管疾病专业委员会草原血管论坛

尊敬的各位同仁:     “2016中国微循环学会周围血管疾病专业委员会草原血管论坛暨国家继续教育培训班20160402061(国)、2016赤峰血管论坛(第四届)、2016赤峰血管护理论坛(第二届)”。将于2016年7月22日至23日在金方大酒店召开。     届时大会邀请中国微循环周围血管疾病专业委员会主任委员、北京协和医院血管外科郑月宏教授;首

Scientif Rep:揭示阻碍疟疾感染的红细胞进行微循环的特殊蛋白

当引发疟疾的疟原虫感染人类红细胞时,它会在宿主细胞中启动一个长达48小时的翻新改造过程,在这个过程的前24小时,一种名为RESA的蛋白质承担了第一项任务:增加宿主细胞膜的僵硬程度。增加宿主细胞膜僵硬度会损伤红细胞在血管中的“游动”尤其是在低温下,这项研究由MIT等研究机构的人员进行,相关研究成果刊登在了近日的国际杂志Scientific Reports上。 这是研究者首次发现蛋白RESA在调节血